Kevin L Schwartz1,2,3, Shaun K Morris4,5,6. 1. Public Health Ontario, 480 University Ave, suite 300, Toronto, Ontario, M5G 1V2, Canada. Kevin.schwartz@oahpp.ca. 2. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. Kevin.schwartz@oahpp.ca. 3. St. Joseph's Health Centre, Toronto, Ontario, Canada. Kevin.schwartz@oahpp.ca. 4. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 5. Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario, Canada. 6. Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: The rise in antimicrobial resistance is an urgent public health threat which, in the absence of intervention, may result in a post-antibiotic era limiting the effectiveness of antibiotics to treat both common and serious infections. Globalization and human migration have profoundly contributed to the spread of drug-resistant bacteria. In this review, we summarize the recent literature on the importance of travelers in the spread of drug-resistant bacterial organisms. Our goal was to describe the importance of travel on a variety of clinically relevant drug-resistant bacterial organisms including extended-spectrum β-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, Salmonella species, as well as other enteric infections. RECENT FINDINGS: Travelers from high income countries, visiting low and middle income countries, frequently acquire drug-resistant bacteria, particularly extended-spectrum β-lactamase-producing Enterobacteriaceae. The highest risk is associated with travel to the Indian subcontinent. Multidrug-resistant enteric infections in travelers from Salmonella spp., Campylobacter spp., and Shigella spp. are increasing. Refugees, pilgrimages, and medical tourists are associated with considerable risk of multiple forms of drug resistance. This review highlights the importance of antimicrobial stewardship, infection control, and surveillance; particularly in low and middle income countries. International leadership with global coordination is vital in the battle against antimicrobial resistance.
PURPOSE OF REVIEW: The rise in antimicrobial resistance is an urgent public health threat which, in the absence of intervention, may result in a post-antibiotic era limiting the effectiveness of antibiotics to treat both common and serious infections. Globalization and human migration have profoundly contributed to the spread of drug-resistant bacteria. In this review, we summarize the recent literature on the importance of travelers in the spread of drug-resistant bacterial organisms. Our goal was to describe the importance of travel on a variety of clinically relevant drug-resistant bacterial organisms including extended-spectrum β-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, Salmonella species, as well as other enteric infections. RECENT FINDINGS: Travelers from high income countries, visiting low and middle income countries, frequently acquire drug-resistant bacteria, particularly extended-spectrum β-lactamase-producing Enterobacteriaceae. The highest risk is associated with travel to the Indian subcontinent. Multidrug-resistant enteric infections in travelers from Salmonella spp., Campylobacter spp., and Shigella spp. are increasing. Refugees, pilgrimages, and medical tourists are associated with considerable risk of multiple forms of drug resistance. This review highlights the importance of antimicrobial stewardship, infection control, and surveillance; particularly in low and middle income countries. International leadership with global coordination is vital in the battle against antimicrobial resistance.
Entities:
Keywords:
Antimicrobial resistance; Antimicrobial stewardship; Migration; Public health; Travel
Authors: Emily E Ricotta; Amanda Palmer; Katie Wymore; Paula Clogher; Nadine Oosmanally; Trisha Robinson; Sarah Lathrop; Jillian Karr; Julie Hatch; John Dunn; Patricia Ryan; David Blythe Journal: Am J Public Health Date: 2014-05-15 Impact factor: 9.308
Authors: A Post; D Martiny; N van Waterschoot; M Hallin; U Maniewski; E Bottieau; M Van Esbroeck; E Vlieghe; S Ombelet; O Vandenberg; J Jacobs Journal: Eur J Clin Microbiol Infect Dis Date: 2017-06-17 Impact factor: 3.267
Authors: Christian J H von Wintersdorff; John Penders; Ellen E Stobberingh; Astrid M L Oude Lashof; Christian J P A Hoebe; Paul H M Savelkoul; Petra F G Wolffs Journal: Emerg Infect Dis Date: 2014-04 Impact factor: 6.883
Authors: Dennis Paquet; Laura Jung; Henning Trawinski; Sebastian Wendt; Christoph Lübbert Journal: Dtsch Arztebl Int Date: 2022-06-07 Impact factor: 8.251
Authors: Marissa S Wirth; Margaret A Fitzpatrick; Katie J Suda; Geneva M Wilson; Swetha Ramanathan; Martin E Evans; Makoto M Jones; Christopher D Pfeiffer; Charlesnika T Evans Journal: Infect Control Hosp Epidemiol Date: 2020-12-11 Impact factor: 6.520
Authors: Allison K Guitor; Amogelang R Raphenya; Jennifer Klunk; Melanie Kuch; Brian Alcock; Michael G Surette; Andrew G McArthur; Hendrik N Poinar; Gerard D Wright Journal: Antimicrob Agents Chemother Date: 2019-12-20 Impact factor: 5.191
Authors: Aditya R Gandhi; Sowmya R Rao; Lin H Chen; Michael D Nelson; Edward T Ryan; Regina C LaRocque; Emily P Hyle Journal: Open Forum Infect Dis Date: 2020-08-26 Impact factor: 3.835